Thomas M. Ross - 10 Oct 2022 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
EVP, Global Sales & Marketing
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
MXCT
Transactions as of
10 Oct 2022
Net transactions value
-$163,693
Form type
4
Filing time
12 Oct 2022, 16:09:48 UTC
Previous filing
29 Mar 2022
Next filing
03 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $20,875 +24,851 $0.8400 24,851 10 Oct 2022 Direct F1
transaction MXCT Common Stock Sale $160,289 -24,851 -100% $6.45 0 10 Oct 2022 Direct F1, F2
transaction MXCT Common Stock Options Exercise $3,597 +4,282 $0.8400 4,282 11 Oct 2022 Direct F1
transaction MXCT Common Stock Sale $27,876 -4,282 -100% $6.51 0 11 Oct 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -24,851 -44% $0.000000 32,149 10 Oct 2022 Common Stock 24,851 $0.8400 Direct F1, F4
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -4,282 -13% $0.000000 27,867 11 Oct 2022 Common Stock 4,282 $0.8400 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.31 to $6.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.40 to $6.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4 This option is fully vested and exercisable.